Corporate Update – Tandem Diabetes Care
Market Performance
- Trading Activity: Tandem Diabetes Care (TNDM) closed the day up 0.85 % at 02:43 PM CET on Wednesday, 21 Oct 2026.
- Current Share Price: USD 16.52 on major exchanges.
- Outstanding Shares: 69.6 million.
- Market Capitalisation: USD 1.1 billion.
- Volume (last 24 h): USD 26.2 million traded.
- Monthly Trend: Down 6.24 % since the previous month‑end.
- Moving Average (200 days): USD 19.08.
- 52‑Week Range: Highest USD 29.65 (24 Feb 2026); Lowest USD 12.26 (15 May 2026).
Insider Transactions
On 15 Oct 2026, a senior executive filed an SEC Form 4 reporting:
- Purchase of several thousand shares of common stock.
- Sale of a smaller block of shares at approximately USD 16 per share.
- Exercise of a restricted‑stock‑unit grant awarded in mid‑2024, converting those units into common shares.
These filings are routine and reflect adjustments to the executive’s equity holdings. No other material corporate actions were disclosed.
Peer Activity (Last 24 h)
| Ticker | % Change | Current Price (USD) | Market Cap (USD) | Notes |
|---|---|---|---|---|
| RPC (RES) | +0.81 % | 6.26 | 1.4 bn | P/E 61.94 |
| CVR (UAN) | +0.65 % | 126.9 | 1.3 bn | P/E 8.41 |
| VISN | +3.09 % | 6.00 | 1.3 bn | |
| TYRA | +5.84 % | 20.47 | 1.3 bn | |
| FRNM | +11.85 % | 14.06 | 1.4 bn | Announced launch of SimpleScreen™ Lung test; test offers single‑draw blood‑based screening for lung and colorectal cancer in adults 50‑80 with significant smoking history. |
Company Overview
Tandem Diabetes Care, Inc. is a San Diego‑based health‑care equipment and supply company that designs, develops, and commercialises products for insulin‑dependent diabetes management. The company’s offerings are sold to the U.S. medical industry. Its shares trade on the Nasdaq stock exchange. Tandem completed its initial public offering on 14 Nov 2013. For additional information, visit www.tandemdiabetes.com .
